Toronto, Ontario–(Newsfile Corp. – March 4, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“ PharmaDrug” or the “Company“) wholly-owned subsidiary, Sariyo Therapeutics Inc. (“Sairiyo”), a biotechnology company focused on the research and development of Cepharanthine, a repurposed and reformulated naturally-derived compound for the potential treatment of cancer, neurological…
